StemGen, Inc.
SGNI
$0.10
$0.06150.00%
| 03/31/2022 | 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -64.66% | -64.66% | -65.44% | 101.03% | 379.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -64.66% | -64.66% | -65.44% | 101.03% | 379.66% |
| Cost of Revenue | -70.22% | -66.84% | -82.53% | 258.82% | 403.75% |
| Gross Profit | -50.92% | -59.89% | -9.80% | -22.02% | 328.95% |
| SG&A Expenses | 137.75% | 89.22% | 142.75% | 139.15% | 52.86% |
| Depreciation & Amortization | 76.02% | 124.86% | 252.57% | 482.38% | 47.10% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 83.30% | 66.16% | 115.59% | 227.05% | 72.02% |
| Operating Income | -131.79% | -124.37% | -194.48% | -263.49% | -42.14% |
| Income Before Tax | -48.27% | -41.91% | -83.14% | -87.65% | -25.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -48.27% | -41.91% | -83.14% | -87.65% | -25.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.27% | -41.91% | -83.14% | -87.65% | -25.83% |
| EBIT | -131.79% | -124.37% | -194.48% | -263.49% | -42.14% |
| EBITDA | -166.35% | -115.05% | -261.89% | -678.11% | -132.46% |
| EPS Basic | -47.50% | -41.43% | -79.66% | -82.69% | -33.33% |
| Normalized Basic EPS | -67.39% | -52.50% | -72.22% | -77.42% | -27.78% |
| EPS Diluted | -47.50% | -41.43% | -79.66% | -82.69% | -33.33% |
| Normalized Diluted EPS | -67.39% | -52.50% | -72.22% | -77.42% | -27.78% |
| Average Basic Shares Outstanding | -0.02% | 0.11% | 0.25% | 0.38% | -4.66% |
| Average Diluted Shares Outstanding | -0.02% | 0.11% | 0.25% | 0.38% | -4.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
